M6D-23255-70525
2 vaccinations
2 coded responses
16 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 953 / CA
- Registered
- 2022-12-16
- Relationship
- Child or adolescent in my care
- Guardian
- UPK-12747-80811
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-13
Dose 1 — Pfizer-BioNTech
-
2022-12-16
Registered in v-safe
- 2022-12-16
- 2022-12-17
- 2022-12-18
- 2022-12-20
- 2022-12-27
-
2023-01-03
Survey response — day 21, dose 1, under 3MedDRA: Norovirus infection — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-01-10
- 2023-01-17
-
2023-01-19
Dose 2 — Pfizer-BioNTech
- 2023-01-24
- 2023-01-26
- 2023-02-02
-
2023-02-09
Survey response — day 21, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
- 2023-02-17
- 2023-02-23
- 2023-03-02
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-13 | Pfizer-BioNTech | No |
| 2 | 2023-01-19 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Norovirus infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release